Cardinal Health Q1 revenue $64B (+22%), non-GAAP EPS $2.55 (+36%); raises FY2026 guidance

CARDINAL HEALTH INC

2026-Q1 EPS reported $1.88 revenue$64,009,000,000

Revenue $64B (+22% YoY); GAAP diluted EPS $1.88 (+11%); non-GAAP diluted EPS $2.55 (+36%).
Segment profit growth across all five segments; Pharmaceutical & Specialty profit up 26% to $667M.
FY2026 non-GAAP EPS guidance raised to $9.65-$9.85 (from $9.30-$9.50); adjusted free cash flow raised to $3.0-$3.5B.
Acquisition of Solaris Health expected to close early November; initiated $375M accelerated share repurchase in Q1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.